Format

Send to:

Choose Destination
See comment in PubMed Commons below
Pol Merkur Lekarski. 2008 Jul;25(145):97-100.

[Biological agents in treatment of psoriatic arthritis].

[Article in Polish]

Author information

  • 1Department of Internal Medicine and Rheumatology, Silesian Medical University of Katowice, Poland. kmnlewiccy@interia.pl

Abstract

Psoriatic arthritis was reported in approximately 6-39% of patients with psoriasis. It is a chronic disease that commonly leads to disability. The paper reviews TNF-alpha inhibitors, the drugs which resulted in a substantial progress in management of psoriatic arthritis. Numerous studies have shown efficacy of these medical agents including inhibition of the disease progress, improvement of skin changes, inhibition of bone destruction, and improvement in quality of life. Other agents which can be used in psoriatic arthritis treatment are being tested in clinical trials.

PMID:
18839626
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk